Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Preventing Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone (Pred-ART)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2013 by University of Cape Town
Institute of Tropical Medicine, Antwerp, Belgium
Imperial College London, United Kingdom
European and Developing Countries Clinical Trials Partnership (Funder)
South African Department of Science and Technology (Funder)
Information provided by (Responsible Party):
Graeme Meintjes, University of Cape Town Identifier:
First received: August 12, 2013
Last updated: September 12, 2013
Last verified: September 2013
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2015
  Estimated Primary Completion Date: February 2015 (Final data collection date for primary outcome measure)